About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Deep Learning CAD Screening on Chest CT | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT07181512

Deep Learning CAD Screening on Chest CT

Coronary artery disease (CAD) is one of the leading causes of death worldwide. Many people have early atherosclerosis without symptoms, and some may develop significant coronary stenosis before any wa...

Lead sponsor: Yifan Guo•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Yifan Guo, MD

CONTACT

+86-18072947783 [email protected]

Sponsors

Lead Sponsor

Yifan Guo

Collaborators

Jinhua Municipal Central Hospital
The Second Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Ningbo University

This study involves analysis of imaging data obtained from patients who undergo non-contrast chest CT and CCTA as part of their routine clinical care. No additional imaging, radiation, or intervention is performed. The institutional review board approved the study and waived the requirement for written informed consent due to minimal risk and use of de-identified data.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age ≥18 years
•2. Patients who underwent both non-contrast chest CT and coronary CT angiography (CCTA) within 30 days
•3. Coronary segments clearly visualized on non-contrast chest CT

Exclusion Criteria

•1. Segments with motion artifacts, metal artifacts, or stents preventing analysis
•2. Vessel lumen completely obscured by calcification (unrecognizable vascular course)
•3. Inability to match coronary segment location between non-contrast chest CT and CCTA

Related studies

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

NCT07324720 · Coronary Artery Disease

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

NCT05770349 · Heart Failure, Coronary Artery Disease

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT06779630 · Coronary Artery Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 17, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateSep 2025

Last updatedFeb 17, 2026

Condition

Coronary Artery Disease Coronary Artery Stenosis Stent

Locations shown

The First Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang

The First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 17, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions